Your browser doesn't support javascript.
loading
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).
Jelinek, Tomas; Mihalyova, Jana; Kascak, Michal; Duras, Juraj; Popkova, Tereza; Benkova, Katerina; Richterova, Petra; Plonkova, Hana; Zuchnicka, Jana; Broskevicova, Lucie; Huvarova, Lucie; Cerna, Lucie; Growkova, Katerina; Simicek, Michal; Havel, Martin; Gumulec, Jaromir; Navratil, Milan; Koristek, Zdenek; Paiva, Bruno; Hajek, Roman.
Afiliación
  • Jelinek T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Mihalyova J; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Kascak M; Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
  • Duras J; Centro de Investigación Médica Aplicada, Clínica Universidad de Navarra, IDISNA, Pamplona, Spain.
  • Popkova T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Benkova K; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Richterova P; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Plonkova H; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Zuchnicka J; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Broskevicova L; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Huvarova L; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Cerna L; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Growkova K; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Simicek M; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Havel M; Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Gumulec J; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Navratil M; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Koristek Z; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Paiva B; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Hajek R; Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
Am J Hematol ; 94(1): E35-E37, 2019 01.
Article en En | MEDLINE | ID: mdl-30370955

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia de Células Plasmáticas / Compuestos Bicíclicos Heterocíclicos con Puentes / Terapia Molecular Dirigida / Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sulfonamidas / Leucemia de Células Plasmáticas / Compuestos Bicíclicos Heterocíclicos con Puentes / Terapia Molecular Dirigida / Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Año: 2019 Tipo del documento: Article País de afiliación: República Checa Pais de publicación: Estados Unidos